Genetic mutation screening in an Italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 156-165

  Castellano, M ^a   Mori, L ^b   Giacche M ^b   Agliozzo, E ^b   Tosini, R ^b   Panarotto, A ^b   Cappelli, C ^b   Mulatero, P ^b   Cumetti, D ^b   Veglio, F ^b   Agabiti Rosei, E ^b  

^a SPEDALI CIVILI   (Italy)

^b NONE

Author keywords

Genetics; Paraganglioma; Pheochromocytoma

Indexed keywords

PROTEIN RET; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE C; SUCCINATE DEHYDROGENASE D; VON HIPPEL LINDAU PROTEIN;

CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; INTRON; ITALY; MEDICAL RECORD REVIEW; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PREVALENCE; SEQUENCE ANALYSIS;

EID: 33845481874     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.016     Document Type: Conference Paper

References (30)

1. BAYSAL, B.E. 2002. Hereditary paraganglioma targets diverse paraganglia. J. Med. Genet. 39: 617-622.
2. GRUFFERMAN, S. et al. 1980. Familial carotid body tumors: case report and epidemiologic review. Cancer Rev. 46: 2116-2122.
3. VAN DER MEY, A.G., P.D. MAASWINKEL-MOOY, C.J. CORNELISSE, et al. 1989. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 2: 1291-1294.
4. BENN, D.E., M.S. CROXSON, K. TUCKER, et al. 2003. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 22:1358-1364.
5. ASHIDA, S., H. OKUDA, M. CHIKAZAWA, et al. 2000. Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin. Cancer. Res. 6: 3817-3822.
6. GIMENEZ-ROQUEPLO, A.P., J. FAVIER, P. RUSTIN, et al. 2002. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J. Clin. Endocrinol. Metab. 87: 4771-4774.
7. CHEN, F. et al. 1995. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5: 66-75.
8. CROSSEY, P.A. et al. 1994. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum. Mol. Genet. 3: 1303-1308
9. CASCON, A., A. CEBRIAN, S. RUIZ-LLORENTE, et al. 2002. SDHB mutation analysis in familial and sporadic phaeochromocytoma identifies a novel mutation. J. Med. Genet. 39: E64.
10. CASCON, A., S. RUIZ-LLORENTE, M.F. FRAGA, et al. 2004. Genetic and epigenetic profile of sporadic pheochromocytomas. J. Med. Genet. 41: e30.
11. CASCON, A., S. RUIZ-LLORENTE, A. CEBRIAN, et al. 2003. G12S and H50R variations are polymorphisms in the SDHD gene. Genes Chromosomes Cancer 37: 220-221.
12. KYTOLA, S., B. NORD, E.E. ELDER, et al. 2002. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas Genes Chromosomes Cancer 34: 325-332.
13. MCWHINNEY, S.R., R.T. PILARSKI, S.R. FORRESTER & M.C. SCHNEIDER 2004. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J. Clin. Endocrinol. Metab. 89: 5694-5699.
14. BAYSAL, B.E., J.E. WILLETT-BROZICK, P.A. FILHO, et al. 2004. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J. Med. Genet. 41: 703-709.
15. BAYLEY, J.P., P. DEVILEE, & P.E. TASCHNER. 2005. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med. Genet. 6: 39.
16. ZEDENIUS, J. et al. 1994. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC. Hum. Mol. Genet. 3: 1259-1262.
17. BELDJORD, C. et al. 1995. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. J. Clin. Endocrinol. Metab. 80: 2063-2068.
18. ENG, C. et al. 1995. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J. Med. Genet. 32: 934-937.
19. LINDOR, N.M., R. HONCHEL, S. THIBODEAU, et al. 1995. Mutations in the RET protooncogene in sporadic pheochromocytomas. J. Clin. Endocrinol. Metab. 80: 627-629.
20. HOFSTRA, R.M. et al. 1996. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J. Clin. Endocrinol. Metab. 81: 2881-2884.
21. TAKAYA, K. et al. 1996. The RET proto-oncogene in sporadic pheochromocytomas. Intern. Med. 35: 449-452.
22. RODIEN, P., X. JEUNEMAITRE, C. DUMONT, et al. 1997. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas. Horm. Res. 47: 263-268.
23. BRAUCH, H. 1997. Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the ret protooncogene. J. Clin. Endocrinol. Metab. 82: 4101-4104.
24. NEUMANN, H.P. et al. 2002. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346: 1459-1466.
25. BAUTERS, C. et al. 2003. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. J. Med. Genet. 40: e75.
26. GIMENEZ-ROQUEPLO, A.P. 2003. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 63: 5615-5621.
27. VAN DER HARST, E. et al. 1998. Germline mutations in the VHL gene in patients presenting with phaeochromocytomas. Int. J. Cancer 77: 337-340.
28. ASTUTI, D., N. HART-HOLDEN, F. LATIF, et al. 2003. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin. Endocrinol. (Oxf) 59: 728-733.
29. NEUMANN, H.P. et al. 2004. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 25: 943-951.
30. CASCON, A. et al. 2002. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Eur. J. Hum. Genet. 10: 457-461.